摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(benzyloxy)-N-(6-methoxy-4-oxo-3-(pyridin-2-ylmethyl)-3,4-dihydroquinazolin-7-yl)acetamide | 1219362-70-5

中文名称
——
中文别名
——
英文名称
2-(benzyloxy)-N-(6-methoxy-4-oxo-3-(pyridin-2-ylmethyl)-3,4-dihydroquinazolin-7-yl)acetamide
英文别名
N-[6-methoxy-4-oxo-3-(pyridin-2-ylmethyl)quinazolin-7-yl]-2-phenylmethoxyacetamide
2-(benzyloxy)-N-(6-methoxy-4-oxo-3-(pyridin-2-ylmethyl)-3,4-dihydroquinazolin-7-yl)acetamide化学式
CAS
1219362-70-5
化学式
C24H22N4O4
mdl
——
分子量
430.463
InChiKey
ZKVAWPAHFCRPKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    32
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    93.1
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    苄氧基乙酰氯 、 在 三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 0.08h, 以50.5%的产率得到2-(benzyloxy)-N-(6-methoxy-4-oxo-3-(pyridin-2-ylmethyl)-3,4-dihydroquinazolin-7-yl)acetamide
    参考文献:
    名称:
    Parallel Solution Phase Synthesis of 3,6,7−4(3H)-Quinazolinones and Evaluation of Their Antitumor Activities against Human Cancer
    摘要:
    Three diversity points of 4(3H)-quinazolinone are introduced at the 3-, 6-, and 7-positions with an efficient parallel solution-phase synthetic method. A one-pot synthesis was developed that gave the key intermediate in high yield. Five hit compounds exhibit preferable activities against a panel of human tumor cell lines, which pointed out preliminary structure-activity relationships.
    DOI:
    10.1021/cc900173s
点击查看最新优质反应信息

文献信息

  • Parallel Solution Phase Synthesis of 3,6,7−4(3<i>H</i>)-Quinazolinones and Evaluation of Their Antitumor Activities against Human Cancer
    作者:Hao Wu、Xilei Xie、Gang Liu
    DOI:10.1021/cc900173s
    日期:2010.5.10
    Three diversity points of 4(3H)-quinazolinone are introduced at the 3-, 6-, and 7-positions with an efficient parallel solution-phase synthetic method. A one-pot synthesis was developed that gave the key intermediate in high yield. Five hit compounds exhibit preferable activities against a panel of human tumor cell lines, which pointed out preliminary structure-activity relationships.
查看更多